These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11185648)

  • 1. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease.
    Kis B; Heberlein I; Hagenah J; Jacobs H; Klein C; Vieregge P
    J Neurol Neurosurg Psychiatry; 2000 Dec; 69(6):838. PubMed ID: 11185648
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease.
    Dujardin K; Duhamel A; Becquet E; Grunberg C; Defebvre L; Destee A
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):323-8. PubMed ID: 10449554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monozygotic twins with Parkinson's disease.
    Koller W; O'Hara R; Nutt J; Young J; Rubino F
    Ann Neurol; 1986 Apr; 19(4):402-5. PubMed ID: 3707095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial aggregation of Parkinson's disease in a Finnish population.
    Autere JM; Moilanen JS; Myllylä VV; Majamaa K
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):107-9. PubMed ID: 10864614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
    Alcalay RN; Mejia-Santana H; Mirelman A; Saunders-Pullman R; Raymond D; Palmese C; Caccappolo E; Ozelius L; Orr-Urtreger A; Clark L; Giladi N; Bressman S; Marder K;
    Parkinsonism Relat Disord; 2015 Feb; 21(2):106-10. PubMed ID: 25434972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort.
    Belarbi S; Hecham N; Lesage S; Kediha MI; Smail N; Benhassine T; Ysmail-Dahlouk F; Lohman E; Benhabyles B; Hamadouche T; Assami S; Brice A; Tazir M
    Parkinsonism Relat Disord; 2010 Dec; 16(10):676-9. PubMed ID: 20933457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial manic-depressive illness and familial Parkinson's disease: a case report.
    Tune LE; Folstein M; Rabins P; Jayaram G; McHugh P
    Johns Hopkins Med J; 1982 Aug; 151(2):65-70. PubMed ID: 7098246
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive impairment in Parkinson's disease.
    Cosgrove J; Alty JE; Jamieson S
    Postgrad Med J; 2015 Apr; 91(1074):212-20. PubMed ID: 25814509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition in Parkinson's disease.
    Braham J; Sadeh M; Modan M
    Neurology; 1989 Oct; 39(10):1411. PubMed ID: 2797472
    [No Abstract]   [Full Text] [Related]  

  • 13. ECT in Parkinson's disease: neuropsychological response.
    Pridmore S; Lowrie A; Holmes G; Pollard C
    Convuls Ther; 1996 Dec; 12(4):257-9. PubMed ID: 9034700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apathy in Parkinson's disease].
    García-Ramos R; Villanueva C; del Val J; Matías-Guíu J
    Neurologia; 2010; 25(1):40-50. PubMed ID: 20388460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairment in prodromal Parkinson's disease.
    Pausch C; Schomburg R; Wagenpfeil S; Wollenweber FA; Bayer C; Fassbender K; Behnke S
    J Neurol Sci; 2016 Dec; 371():117-120. PubMed ID: 27871431
    [No Abstract]   [Full Text] [Related]  

  • 17. The neuropsychological profile of Othello syndrome in Parkinson's disease.
    Foley JA; Warner TT; Cipolotti L
    Cortex; 2017 Nov; 96():158-160. PubMed ID: 28917380
    [No Abstract]   [Full Text] [Related]  

  • 18. Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.
    Baig F; Lawton M; Rolinski M; Ruffmann C; Nithi K; Evetts SG; Fernandes HR; Ben-Shlomo Y; Hu MT
    Mov Disord; 2015 Nov; 30(13):1759-66. PubMed ID: 26179331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric aspects of Parkinson's disease.
    Marsh L
    Psychosomatics; 2000; 41(1):15-23. PubMed ID: 10665264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PD.
    Gosal D; Ross OA; Wiley J; Irvine GB; Johnston JA; Toft M; Mata IF; Kachergus J; Hulihan M; Taylor JP; Lincoln SJ; Farrer MJ; Lynch T; Mark Gibson J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):349-52. PubMed ID: 16102999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.